FRAIL-AF: Switching to NOACs in Older, Frail Patients Linked to Increased Bleeding Risk
Results of the FRAIL-AF trial at ESC Congress 2023 provide clinicians with further clarity into the effects of switching from vitamin K antagonists to NOACs in older patients with frailty and atrial fibrillation.
Source: hcplive.com